These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34507995)

  • 21. Ablation of the
    Bröer A; Gauthier-Coles G; Rahimi F; van Geldermalsen M; Dorsch D; Wegener A; Holst J; Bröer S
    J Biol Chem; 2019 Mar; 294(11):4012-4026. PubMed ID: 30635397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.
    Lu H; Li X; Lu Y; Qiu S; Fan Z
    Cancer Lett; 2016 Oct; 381(1):23-30. PubMed ID: 27450723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-Substituted Nγ-glutamylanilides as novel probes of ASCT2 with improved potency.
    Schulte ML; Dawson ES; Saleh SA; Cuthbertson ML; Manning HC
    Bioorg Med Chem Lett; 2015 Jan; 25(1):113-6. PubMed ID: 25435145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sorting nexin 27 (SNX27) regulates the trafficking and activity of the glutamine transporter ASCT2.
    Yang Z; Follett J; Kerr MC; Clairfeuille T; Chandra M; Collins BM; Teasdale RD
    J Biol Chem; 2018 May; 293(18):6802-6811. PubMed ID: 29563155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the glutamine transporter ASCT2 in antineoplastic therapy.
    Teixeira E; Silva C; Martel F
    Cancer Chemother Pharmacol; 2021 Apr; 87(4):447-464. PubMed ID: 33464409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neddylation inhibition induces glutamine uptake and metabolism by targeting CRL3
    Zhou Q; Lin W; Wang C; Sun F; Ju S; Chen Q; Wang Y; Chen Y; Li H; Wang L; Hu Z; Jin H; Wang X; Sun Y
    Nat Commun; 2022 May; 13(1):3034. PubMed ID: 35641493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and Synthesis of Hydroxy-l-Proline Blockers of the Neutral Amino Acid Transporters SLC1A4 (ASCT1) and SLC1A5 (ASCT2).
    Lyda BR; Leary GP; Farnsworth J; Seaver B; Silvius D; Kavanaugh MP; Esslinger CS; Natale NR
    Molecules; 2024 May; 29(10):. PubMed ID: 38792190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conserved allosteric inhibition mechanism in SLC1 transporters.
    Dong Y; Wang J; Garibsingh RA; Hutchinson K; Shi Y; Eisenberg G; Yu X; Schlessinger A; Grewer C
    Elife; 2023 Mar; 12():. PubMed ID: 36856089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cysteine is not a substrate but a specific modulator of human ASCT2 (SLC1A5) transporter.
    Scalise M; Pochini L; Pingitore P; Hedfalk K; Indiveri C
    FEBS Lett; 2015 Nov; 589(23):3617-23. PubMed ID: 26492990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth.
    Bothwell PJ; Kron CD; Wittke EF; Czerniak BN; Bode BP
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30029480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining substrate and blocker activity of alanine-serine-cysteine transporter 2 (ASCT2) Ligands with Novel Serine Analogs.
    Albers T; Marsiglia W; Thomas T; Gameiro A; Grewer C
    Mol Pharmacol; 2012 Mar; 81(3):356-65. PubMed ID: 22113081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voltage-dependent processes in the electroneutral amino acid exchanger ASCT2.
    Zander CB; Albers T; Grewer C
    J Gen Physiol; 2013 Jun; 141(6):659-72. PubMed ID: 23669717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer.
    Wang L; Liu Y; Zhao TL; Li ZZ; He JY; Zhang BJ; Du HZ; Jiang JW; Yuan ST; Sun L
    Phytomedicine; 2019 Apr; 57():117-128. PubMed ID: 30668314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASCT2: a potential cancer drug target.
    Wahi K; Holst J
    Expert Opin Ther Targets; 2019 Jul; 23(7):555-558. PubMed ID: 31159623
    [No Abstract]   [Full Text] [Related]  

  • 35. The involvement of sodium in the function of the human amino acid transporter ASCT2.
    Mazza T; Scalise M; Pappacoda G; Pochini L; Indiveri C
    FEBS Lett; 2021 Dec; 595(24):3030-3041. PubMed ID: 34741534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors.
    Prelowska MK; Mehlich D; Ugurlu MT; Kedzierska H; Cwiek A; Kosnik A; Kaminska K; Marusiak AA; Nowis D
    Cancer Lett; 2021 Jun; 507():13-25. PubMed ID: 33713737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development.
    Wang Q; Hardie RA; Hoy AJ; van Geldermalsen M; Gao D; Fazli L; Sadowski MC; Balaban S; Schreuder M; Nagarajah R; Wong JJ; Metierre C; Pinello N; Otte NJ; Lehman ML; Gleave M; Nelson CC; Bailey CG; Ritchie W; Rasko JE; Holst J
    J Pathol; 2015 Jul; 236(3):278-89. PubMed ID: 25693838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells.
    Polet F; Martherus R; Corbet C; Pinto A; Feron O
    Oncotarget; 2016 Jul; 7(29):46371-46383. PubMed ID: 27344174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site.
    Esslinger CS; Cybulski KA; Rhoderick JF
    Bioorg Med Chem; 2005 Feb; 13(4):1111-8. PubMed ID: 15670919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pro-proliferative effect of interferon-γ in breast cancer cell lines is dependent on stimulation of ASCT2-mediated glutamine cellular uptake.
    Silva C; Andrade N; Rodrigues I; Ferreira AC; Soares ML; Martel F
    Life Sci; 2021 Dec; 286():120054. PubMed ID: 34662550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.